Steinitz M, Livoff A, Tamir S, Brenner T
Department of Pathology, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Med Oncol Tumor Pharmacother. 1993;10(1-2):49-52. doi: 10.1007/BF02987768.
A universal method for selection of surface marker-positive cells is described. The cells, admixed with an excess of surface marker-negative cells, are first labelled with a specific biotinylated ligand and then isolated with the aid of monoclonal, anti-biotin coated beads. The method enables selection and isolation of cells with a frequency as low as 10(-4). The ligand can be an antigen (for selection of infrequent antibody-producing cells), an antibody (for selection of surface antigen-positive cells) or other molecules (for selection of specific receptor-positive cells).